Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

90 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The Impact of COVID-19 on Patients with IBD in a Prospective European Cohort Study.
Amiot A, Rahier JF, Baert F, Nahon S, Hart A, Viazis N, Biancone L, Domenech E, Reenears C, Peyrin-Biroulet L, Beaugerie L, Burisch J; I-CARE collaborator group. Amiot A, et al. Among authors: viazis n. J Crohns Colitis. 2023 Jan 27;17(1):37-48. doi: 10.1093/ecco-jcc/jjac091. J Crohns Colitis. 2023. PMID: 35767639 Free PMC article.
Risankizumab versus Ustekinumab for Moderate-to-Severe Crohn's Disease.
Peyrin-Biroulet L, Chapman JC, Colombel JF, Caprioli F, D'Haens G, Ferrante M, Schreiber S, Atreya R, Danese S, Lindsay JO, Bossuyt P, Siegmund B, Irving PM, Panaccione R, Cao Q, Neimark E, Wallace K, Anschutz T, Kligys K, Duan WR, Pivorunas V, Huang X, Berg S, Shu L, Dubinsky M; SEQUENCE Study Group. Peyrin-Biroulet L, et al. N Engl J Med. 2024 Jul 18;391(3):213-223. doi: 10.1056/NEJMoa2314585. N Engl J Med. 2024. PMID: 39018531 Clinical Trial.
Randomised clinical trial: otilonium bromide improves frequency of abdominal pain, severity of distention and time to relapse in patients with irritable bowel syndrome.
Clavé P, Acalovschi M, Triantafillidis JK, Uspensky YP, Kalayci C, Shee V, Tack J; OBIS Study Investigators. Clavé P, et al. Aliment Pharmacol Ther. 2011 Aug;34(4):432-42. doi: 10.1111/j.1365-2036.2011.04730.x. Epub 2011 Jun 16. Aliment Pharmacol Ther. 2011. PMID: 21679214 Free article. Clinical Trial.
Pregnancy outcomes in Greek women with inflammatory bowel disease: a longitudinal national retrospective study.
Papathanasiou E, Kokkotis G, Axiaris G, Bellou G, Chalakatevaki K, Christidou A, Christodoulou DK, Foteinogiannopoulou K, Gatopoulou A, Giouleme O, Gkoumas K, Κalogirou M, Karatzas P, Κarmiris K, Κatsanos K, Κourikou A, Κoutroubakis IE, Liatsos C, Mantzaris GJ, Μathou N, Michalopoulos G, Μantaka A, Nikolaou P, Oikonomou M, Papatheodoridis G, Polymeros D, Skouloudis E, Soufleris K, Stergiou E, Theodoulou A, Theodoropoulou A, Theoxaris G, Tsafaraki S, Tsiolakidou G, Tsironi E, Tzouvala M, Viazis N, Michopoulos S, Bamias G, Zampeli E. Papathanasiou E, et al. Among authors: viazis n. Eur J Gastroenterol Hepatol. 2024 Sep 23. doi: 10.1097/MEG.0000000000002844. Online ahead of print. Eur J Gastroenterol Hepatol. 2024. PMID: 39324945
Diagnostic Yield and Outcomes of Small Bowel Capsule Endoscopy in Patients with Small Bowel Bleeding Receiving Antithrombotics.
Viazis N, Christodoulou D, Papastergiou V, Mousourakis K, Kozompoli D, Stasinos G, Dimopoulou K, Apostolopoulos P, Fousekis F, Liatsos C, Kyriakos N, Argyropoulos T, Tribonias G. Viazis N, et al. Diagnostics (Basel). 2024 Jun 27;14(13):1361. doi: 10.3390/diagnostics14131361. Diagnostics (Basel). 2024. PMID: 39001251 Free PMC article.
An international multicentre study of SwiTching from Intravenous to subcutaneous inflixiMab and vEdolizumab in inflammatory bowel diseases: The TIME study.
D'Amico F, Massimino L, Palmieri G, Dal Buono A, Gabbiadini R, Caron B, Moreira P, Silva I, Bosca-Watts M, Innocenti T, Dragoni G, Bezzio C, Zilli A, Furfaro F, Saibeni S, Chaparro M, García MJ, Michalopoulos G, Viazis N, Mantzaris GJ, Ellul P, Gisbert JP, Magro F, Peyrin-Biroulet L, Armuzzi A, Ungaro F, Danese S, Fiorino G, Allocca M. D'Amico F, et al. Among authors: viazis n. Eur J Clin Invest. 2024 Nov;54(11):e14283. doi: 10.1111/eci.14283. Epub 2024 Jul 9. Eur J Clin Invest. 2024. PMID: 38979834
Comparison between tofacitinib and ustekinumab as a third-line therapy in refractory ulcerative colitis: A multicenter international study.
Allocca M, Catalano G, Savarino EV, Chaparro M, Levartovsky A, Michalopoulos G, Viazis N, Fousekis FS, Psistakis A, Noviello D, Nascimento CND, Caron B, Kitsou V, Bamias G, García MJ, Zacharopoulou E, Foteinogiannopoulou K, D'Amico F, Koutroubakis I, Ellul P, Tzouvala M, Peyrin-Biroulet L, Torres J, Caprioli F, Karmiris K, Theodoropoulou A, Katsanos KH, Christodoulou DK, Mantzaris GJ, Kopylov U, Gisbert JP, Danese S, Magro F, Carla F, Fiorino G. Allocca M, et al. Among authors: viazis n. United European Gastroenterol J. 2024 Jun;12(5):543-551. doi: 10.1002/ueg2.12492. Epub 2024 Feb 28. United European Gastroenterol J. 2024. PMID: 38419274 Free PMC article.
Curcumin-QingDai Combination for Patients With Active Ulcerative Colitis: A Randomized, Double-Blinded, Placebo-Controlled Trial.
Ben-Horin S, Salomon N, Karampekos G, Viazis N, Lahat A, Ungar B, Eliakim R, Kuperstein R, Kriger-Sharabi O, Reiss-Mintz H, Yanai H, Dotan I, Zittan E, Maharshak N, Hirsch A, Weitman M, Mantzaris GJ, Kopylov U. Ben-Horin S, et al. Among authors: viazis n. Clin Gastroenterol Hepatol. 2024 Feb;22(2):347-356.e6. doi: 10.1016/j.cgh.2023.05.023. Epub 2023 Jun 9. Clin Gastroenterol Hepatol. 2024. PMID: 37302449 Clinical Trial.
90 results